Corundum Group’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7
| Closed | -$11.6K | – | 110 |
|
|
2023
Q3 | $11.6K | Hold |
7
| – | – | 0.01% | 100 |
|
|
2023
Q2 | $29.4K | Hold |
7
| – | – | 0.01% | 113 |
|
|
2023
Q1 | $33.7K | Hold |
7
| – | – | 0.02% | 97 |
|
|
2022
Q4 | $23K | Hold |
7
| – | – | 0.01% | 99 |
|
|
2022
Q3 | $51K | Hold |
7
| – | – | 0.03% | 103 |
|
|
2022
Q2 | $43K | Hold |
7
| – | – | 0.03% | 93 |
|
|
2022
Q1 | $91K | Hold |
7
| – | – | 0.08% | 95 |
|
|
2021
Q4 | $119K | Buy |
7
+3
| +75% | +$51K | 0.08% | 100 |
|
|
2021
Q3 | $81K | Hold |
4
| – | – | 0.06% | 90 |
|
|
2021
Q2 | $71K | Buy |
+4
| New | +$71K | 0.05% | 100 |
|